Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « Teeft.i » - entrée « Vaccinia »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccine virus < Vaccinia < Vaccinia virions  Facettes :

List of bibliographic references indexed by Vaccinia

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
001714 (2006) Yasuko Tsunetsugu-Yokota [Japon] ; Kazuo Ohnishi [Japon] ; Toshitada Takemori [Japon]Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
001781 (2005) Girish J. Kotwal [Afrique du Sud] ; Jennifer N. Kaczmarek [Afrique du Sud] ; Steven Leivers [Afrique du Sud] ; Yohannes T. Ghebremariam [Afrique du Sud] ; Amod P. Kulkarni [Afrique du Sud] ; Gabriele Bauer [Afrique du Sud] ; Corena De Beer [Allemagne] ; Wolfgang Preiser [Allemagne] ; Abdu Rahman Mohamed [Afrique du Sud]Anti‐HIV, Anti‐Poxvirus, and Anti‐SARS Activity of a Nontoxic, Acidic Plant Extract from the Trifollium Species Secomet‐V/anti‐Vac Suggests That It Contains a Novel Broad‐Spectrum Antiviral
001961 (1998) Per Johan Klasse [Royaume-Uni] ; Romke Bron [Royaume-Uni] ; Mark Marsh [Royaume-Uni]Mechanisms of enveloped virus entry into animal cells
001967 (1998) John Lubinski [États-Unis] ; Thandavarayan Nagashunmugam [États-Unis] ; Harvey M. Friedman [États-Unis]Viral interference with antibody and complement
001A97 (1993) Christopher W. Olsen [États-Unis]A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination
001B31 (1992) Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
001B37 (1992) Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus
001B45 (1992) Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
001B46 (1992) H. Vennema [Pays-Bas] ; J. W. A. Rossen [Pays-Bas] ; J. Wesseling [Pays-Bas] ; M. C. Horzinek [Pays-Bas] ; P. J. M. Rottier [Pays-Bas]Genomic organization and expression of the 3′ end of the canine and feline enteric coronaviruses
001B52 (1992) Gareth Griffiths [Allemagne] ; Peter Rottier [Pays-Bas]Cell biology of viruses that assemble along the biosynthetic pathway
001C08 (1990) Linda Christen [États-Unis] ; Janny Seto [États-Unis] ; Edward G. Niles [États-Unis]Superinfection exclusion of vaccinia virus in virus-infected cell cultures
001C99 (1988) Abstracts of Papers Presented at the Session of the Virology Section of the Deutsche Gesellschaft für Hygiene und Mikrobiologie, Martinsried, March 25–28, 1987
001D04 (1987) Vaccine for use in cases of sheep foot-rot comprising at least one protease of Bacteroides nodosus
001D06 (1987) Subject index
001D21 (1987) Beate Schwer ; Paolo Visca ; Jan C. Vos ; Hendrik G. StunnenbergDiscontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5′ poly(A) leader
001D43 (1986) Vaccine against Schistosoma mansoni containing soluble antigen from larvae or adults
001D48 (1986) Strain-independent inactivated influenza vaccine production by removal of the hemagglutinin heavy HA1 chain
001D53 (1986) Oral vaccine production by inactivating virus in the presence of protective compounds from the culture medium, adding further stabilizer and then freeze-drying
001D56 (1986) Inactivated poultry plague vaccine from virus Newcastle disease culture in incubated hen egg
001D57 (1986) Inactivated pigeon herpes virus vaccine from chicken fibroblast cell culture
001D59 (1986) Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Vaccinia" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Vaccinia" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Vaccinia
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021